May 2015
No Appellate Jurisdiction over Denied Motions to Stay Pending Covered Business Method Review Until Board Institutes a Proceeding
1, 2015)
[Appealed from S.D.N.Y., Judge Hellerstein]
[Appealed fromN.D. Cal., Judge Seeborg]
An Overly Narrow Statement of the Problem in an Obviousness Challenge Can Represent a Form of Prohibited Reliance on Hindsight
[Appealed from D.N.J., Judge Cooper]
PTO’s Refusal to Terminate Pending Reexaminations Is Not Appealable
[Appealed from E.D. Va., Judge Trenga]
Federal Circuit Reverses District Court’s Denial of Attorneys’ Fees in View of Octane Fitness
[Appealed from C.D. Cal., Senior Judge Pfaelzer]
A Range Disclosed by the Prior Art Is Only Anticipatory If It Describes the Claimed Range with Sufficient Specificity
[Appealed from S.D. Tex., Judge Costa]
Trademark That Is Descriptive of Nutritional Supplement Ingredients Is Not Registrable
No. 14-1383 (Fed. Cir. Apr. 17, 2015)
[Appealed from TTAB]
A Single Embodiment Does Not Restrict Claim Construction to the Embodiment in the Absence of a Clear Intention to Do So
No. 13-1528 (Fed. Cir. Apr. 24, 2015)
[Appealed from S.D. Ohio, Judge Black]
Exclusion of Patentee’s Damages Evidence Is Insufficient to Justify SJ of No Damages
[Appealed from S.D. Ohio, Judge Black]
Federal Circuit Maintains Reversal of District Court’s Determination of Indefiniteness Under Supreme Court’s “Reasonable Certainty” Standard
[Appealed from S.D.N.Y., Judge Hellerstein]
Abbreviations | |
AIA | America Invents Act |
ALJ | Administrative Law Judge |
ANDA | Abbreviated New Drug Application |
APA | Administrative Procedures Act |
APJ | Administrative Patent Judge |
Board | Patent Trial and Appeal Board (formerly the Board of Patent Appeals and Interferences) |
Commissioner | Commissioner of Patents and Trademarks |
CIP | Continuation-in-Part |
DJ | Declaratory Judgment |
DOE | Doctrine of Equivalents |
FDA | Food and Drug Administration |
IDS | Information Disclosure Statement |
ITC | International Trade Commission |
JMOL | Judgment as a Matter of Law |
MPEP | Manual of Patent Examining Procedure |
NDA | New Drug Application |
PCT | Patent Cooperation Treaty |
PTO | United States Patent and Trademark Office |
SJ | Summary Judgment |
TTAB | Trademark Trial and Appeal Board |